Related Experiment Videos
Isolation and characterization of canine factor IX
Y Sugahara1, J Catalfamo, M Brooks
1Department of Human Genetics, University of Michigan Medical School, Ann Arbor 48109-0618, USA.
Thrombosis and Haemostasis
|March 1, 1996
Summary
Researchers purified canine factor IX, a key protein for blood clotting, and developed a method to measure its levels. This helps in understanding canine hemophilia B and developing new treatments.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Canine hemophilia B is a genetic bleeding disorder.
- Understanding canine factor IX is crucial for studying this condition.
- A quantitative assay for canine factor IX is needed.
Purpose of the Study:
- To purify canine factor IX to homogeneity.
- To characterize its biochemical properties.
- To develop a quantitative assay for canine factor IX antigen.
Main Methods:
- Purification using barium citrate precipitation and multiple chromatography steps.
- Molecular size determination via SDS-PAGE.
- Amino acid sequencing and ELISA for antigen quantification.
Main Results:
- Canine factor IX purified with a molecular size of 61 kDa.
- Identified a 50 kDa species due to proteolytic cleavage.
- Established a normal plasma concentration of 5.3 µg/ml.
- Measured significantly reduced factor IX levels in hemophilia B dogs and carriers.
Conclusions:
- A reliable method for quantifying canine factor IX antigen was developed.
- This assay is essential for hemophilia B research in dogs.
- Findings support the use of canine models for gene therapy studies.